QuickView for C-2k;jsessionid=00427EC40D24125E17992DBD0FBCB338;jsessionid=408DB163D76113CFD6B78C68DEDB5B0C;jsessionid=C8A7CFEC76A7D0C85B897077A1FC6CE4;jsessionid=757F34FC18227D1ADA9D48F8D7605EE0 (gene)

1. CDK9 inhibitors for the treatment of solid tumors.
2. Transcriptional regulation and therapeutic potential of cyclin-dependent kinase 9 (CDK9) in sarcoma.
3. Potent inhibitors targeting cyclin-dependent kinase 9 discovered via virtual high-throughput screeni…
4. Selective inhibition of CDK9 in triple negative breast cancer.
5. Identification of a Novel Selective CDK9 Inhibitor for the Treatment of CRC: Design, Synthesis, and …

There were no clinical trials for C-2k;jsessionid=00427EC40D24125E17992DBD0FBCB338;jsessionid=408DB163D76113CFD6B78C68DEDB5B0C;jsessionid=C8A7CFEC76A7D0C85B897077A1FC6CE4;jsessionid=757F34FC18227D1ADA9D48F8D7605EE0